Nevirapine

Key facts

Invented name
Viramune
Active substance
nevirapine
Therapeutic area
Infectious diseases
Decision number
P/26/2010
PIP number
Nevirapine
Pharmaceutical form(s)
  • Prolonged release tablet
  • Tablet
  • Oral suspension
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Applicant: Boehringer Ingelheim International GmbH
E-mail: paediatrics@boehringer-ingelheim.com
Country: Germany
Phone: +49 6132778271
Fax: +49 6132776601
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000391-PIP01-08-M01
Compliance opinion date
06/08/2010
Compliance outcome
positive

Decision

How useful was this page?

Add your rating